Clinical Trial Update: Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the impact of HIV protease inhibitor drugs on glucose and insulin metabolism. The study sponsored by Bristol-Myers Squibb has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV protease inhibitors (class)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 1 | Status: COMPLETED